Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.

Background: Patients with major depressive disorder who do not respond to ≥2 different pharmacological treatments within the current depressive episode are considered to have treatment resistant depression (TRD). This analysis determined meaningful change thresholds (MCT) of the Patient Health Quest...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Affective Disorders Vol. 281; pp. 767 - 776
Autores principales:	Hudgens, Stacie, Floden, Lysbeth, Blackowicz, Michael, Jamieson, Carol, Popova, Vanina, Fedgchin, Maggie, Drevets, Wayne C., Cooper, Kimberly, Lane, Rosanne, Singh, Jaskaran
Formato:	research tables/charts Journal Article
Publicado:	Elsevier B.V. Feb2021
Acceso en línea:	Ver este registro en EBSCOhost